Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Discovery Building, Sygnature Discovery’s HQ, nominated for RICS Awards 2018, East Midlands

26th February 2018 – Nottingham, UK – The Discovery Building, Sygnature Discovery’s HQ, has been nominated for the RICS Awards 2018, East Midlands.

RICS is the global professional body promoting and enforcing the highest international standards in the valuation, management and development of land, real estate, construction and infrastructure.  With eight categories, the RICS Awards are the premier property and construction awards in the country. The RICS Awards recognise the most innovative projects in the region and their impact on local communities.  Hence, Sygnature Discovery is delighted to be housed in a statement building which is a key component in the regeneration of Nottingham Eastside and also the future of our company.

The RICS Awards 2018, East Midlands, ceremony will take place at the Nottingham Belfry hotel on 3rd May 2018.

Latest News

View All

Sygnature Discovery and Daewoong Pharma announce research…

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…